课题基金 / 基金详情

An atempt of gene therapy for oral squamous cell carcinoma

An atempt of gene therapy for oral squamous cell carcinoma
口腔鳞状细胞癌基因治疗的尝试
批准号:
11557130
负责人:
SHINDOH Masanobu
金额:
$8.32万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

SHINDOH Masanobu的其他基金

相似基金

相关文献

中文摘要
翻译
我们研究了ElAF和Bax的激活,因为ElAF被证明可以激活细胞周期抑制分子p21waf1/cip1的启动子活性。将bax报告质粒、ElAF、野生型(wt)或突变型(mt) p53表达质粒转染到p53缺乏细胞系中,采用CAT (Chloramphenicol acetyl transferase)检测bax的启动子活性。CAT活性随ElAF呈剂量依赖性增加,并且在wt p53和ElAF中观察到启动子活性的协同增加。Western blotting证实了Bax蛋白在转染ElAF细胞中的表达。生长抑制实验显示,ElAF转染的p53缺乏细胞中菌落形成减少。这些结果表明,ElAF与p53通过激活bax诱导细胞凋亡。E4orf6是一种新发现的腺病毒癌蛋白。E4orf6显著增强转化大鼠BRK细胞和人293细胞在裸鼠体内形成肿瘤的能力。E4orf6蛋白已被证明与p53和p73基因产物相互作用,并阻断由这些反基因介导的细胞凋亡的诱导。我们研究了E4orf6是否可以影响p53家族以外的诱导凋亡的分子,因为p53独立的凋亡途径也被提出。我们证明了腺病毒E4orf6蛋白抑制bbnip3的凋亡活性,bbnip3是Bcl-2家族的一组凋亡启动子。E4orf6的表达抑制bnip3介导的细胞凋亡及其线粒体易位。E4orl6与BNIP3相互作用。此外,E4orf6的核输出信号对于E4orf6的这些功能也很重要。我们的数据表明,Bcl-2家族的促凋亡蛋白是转化细胞中E4orf6蛋白的靶标。
英文摘要
ElAF and Bax activation was investigated since ElAF was shown to activate promoter activity of p21waf1/cip1, a cell cycle inhibitory molecule.CAT (Chloramphenicol acetyl transferase) assay was carried out to determine the promoter activity of bax by transfectipn with bax reporter plasmid, ElAF, wild type (wt) or mutant (mt) p53 expression plasmids into a p53 diffident cell line. CAT activity increased with ElAF in a dose-dependent manner and synergistical increase of the promoter activity was observed with wt p53 and ElAF. Protein expression of Bax was confirmed in ElAF transfected cells by Western blotting. Growth suppression assay was performed and decreased colony formation was observed in ElAF transfected p53 diffident cells. These results suggest that ElAF associates with p53 to induce apoptosis through activating bax.E4orf6 is a newly identified viral oncoprotein of the adenovirus. E4orf6 markedly enhances the ability of transformed rat BRK and human 293 cells to form tumors in nude mice. The E4orf6 protein has been shown to interact with p53 and p73 gene products and to block the induction of apoptosis which is mediated by these antioncogenes. We investigated whether or not E4orf6 can influence molecules that induce apoptosis other than the p53 family, because p53-independent apoptosis pathways have also been proposed. We demonstrate that the adenovirus E4orf6 protein suppresses the apoptotic activity of BNIP3, a member of a group of an apoptosis initiators of the Bcl-2 family. Expression of E4orf6 inhibits BNIP3-mediated apoptosis and its mitochondrial translocation. E4orl6 interacts with BNIP3. In addition, the nuclear export signal of E4orf6 is important for these functions of E4orf6. Our data suggest that the pro-apoptotic protein of the Bcl-2 family is a target of the E4orf6 protein in transformed cells.
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroumi H, Dosaka-Akita H, Shindoh M et al.: "Expression of E1AF an ets-related transcription factor in human non-small cell lung cancers : Its relevance in cell motility and inivasion"Int. J. Cancer. 93. 786-791 (2001)
Hiroumi H、Dosaka-Akita H、Shindoh M 等人:“人类非小细胞肺癌中 ets 相关转录因子 E1AF 的表达:其与细胞运动和侵袭的相关性”Int。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ara T., Deyama Y., Yoshimura Y., Higashino F., Shindoh M., Matsumoto A., Fukuda H.: "Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade"Cancer Letts.. 157. 115
Ara T.、Deyama Y.、Yoshimura Y.、Higashino F.、Shindoh M.、Matsumoto A.、Fukuda H.:“E-钙粘蛋白通过抑制丝裂原激活蛋白来调节膜 1 型基质金属蛋白酶的表达
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Aoyagi M., Higashino F., Yasuda M., Kohgo T., Sano H., Shindoh M.: "Adenovirus E4orf6 suppresses the function apoptotic activity by Bcl-2 family protein, BNIP3"Jpn. J. Oral Biol.. 44. 40-47 (2002)
Aoyagi M.、Higashino F.、Yasuda M.、Kohgo T.、Sano H.、Shindoh M.:“腺病毒 E4orf6 通过 Bcl-2 家族蛋白 BNIP3 抑制功能凋亡活性”Jpn。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 10 条
    Development of gene delivery system using nanocoloid and its application for gene targeting therapy
    • 批准号:
      18390531
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.76万
    • 财政年份:
      2006
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Gene targeting therapy for oral carcinoma using adrenomedullin antagonisit.
    • 批准号:
      16390575
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2004
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Research on factors involved in prognosis of oral carcinoma.
    • 批准号:
      14370654
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2002
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    Gene therapy for oral squamous cell carcinoma targeting tumor specific promoter activation
    • 批准号:
      12671834
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2000
    • 负责人:
      SHINDOH Masanobu
    • 依托单位:
    国内基金
    海外基金
    Circ_0001313/miR-338-3p经P53调控铁死亡降低结直肠癌放化疗敏感性的机制
    基于影像组学与代谢组学特征图谱的机器学习模型在P53突变型子宫内膜癌中的临床应用研究
    • 批准号:
      2026JJ82384
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      颜志鹏
    • 依托单位:
    APR-246靶向突变p53通路逆转DLBCL耐药的分子功能及机制研究
    • 批准号:
      JCZRQNB202600696
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄芩素通过p53信号通路逆转胃黏膜肠上皮化生的机制研究